Psychedelic depression drugs

Depression, anxiety, and post-traumatic stress disorder (PTSD) are among the most intractable conditions of our time. Modern society seems to be good at creating the ground on which they thrive. We have only recently realized that simple molecules that could help these conditions have been known for decades.

Timothy Leary, a Harvard professor of psychology of the 1960s, promoted psychedelic drugs, but his goals were vague. Turn on, tune in, drop out, Leary’s admonition was directed at people who thought their minds would be expanded, and perhaps they were, but Leary’s prescription for fulfillment was not helpful to scientists and physicians seeking therapies for depression and anxiety. The drugs also scared the FDA and other government officials because they were part of the 1960s counterculture movement. They could be dangerous. Psychedelics were banned in 1970.

Banned drugs, like banned books, have a way of reappearing. Ketamine, psilocybin, LSD, and MDMA can have extraordinary effects, including hallucinations and an expansive view of life.

They are simple compounds and easy for chemists to make. Psychedelic drugs bind to important elements called receptors in neurons. Psilocybin, from a family of mushrooms, has been used for centuries by Native Americans, as part of cultural and religious practice.

Matthew W. Johnson and Roland R. Griffiths of Johns Hopkins wrote a 2017 review of the therapeutic effects of psilocybin for depression and other conditions. They and other researchers have pulled some of these drugs out of administrative limbo. [See the link below.]

Ketamine was approved by the FDA since 1970, the same year that other psychedelic drugs were banned. It is a sedative and anesthetic for children, and it remained available for other uses. Profoundly depressed patients, who had not been helped by serotonin uptake inhibitors like Prozac which act slowly, quickly responded to ketamine. Except for ketamine, the 1970 ban stopped research funding for psychedelic research, but their use continued underground.

Michael Pollan, Professor of Psychology at UC Berkeley, recounted his own experiences taking these drugs, and provides a history of their development and use in his book “How to Change Your Mind.”

The bans lasted until the late 1990’s when clinical trials were permitted by The National Institutes of Mental Health for patients with major depressive disorder and anxiety in terminally ill cancer patients. Post-traumatic stress disorder has also been studied. Clinical trials are not easy to do. So, the numbers are small.

A specific dose of pure psilocybin or ketamine causes sedation and then a psychedelic trip, with auditory and visual hallucinations, sometimes of an extraordinary nature that can, in the patient’s perception, touch on the divine, and block the ability to distinguish reality and fantasy.

Patients report a loss of ego. A guide always attends and is important to the results. Relief from depression occurs quickly and lasts for months after the drug has disappeared and the patient’s brain has reassembled a rationale view of the world. Most drugs act only when present in the brain above a particular concentration. That said, a bad trip can be terrifying and the memory of it endures.

All psychiatric conditions have a physical basis in nerve cells and the circuits they form.

Instinctively, many people (including me) think of non-corporeal causes, but there is no devil or evil spirit here. There are physical structures and neuronal circuits that can be touched by psychedelics or other drugs, or by electroshock. It looks like psychedelics can do that, but how they do it is unclear.

Syndromes like PTSD lead to self-treatment with opioids or alcohol. Not to study these the psychedelics would be irresponsible. But it will not be simple—there are many neurological conditions and numerous psychedelics. Drug concentrations and methods of application make a difference, as does coordinated psychotherapy. I predict that there will be cultural objections to using these drugs.

I wrote four columns on opioids a few years ago that provided background and described the neurons and receptors involved in euphoria and in controlling breathing. The columns described then current treatments that worked and some that do not. We do not know how psychedelics work on symptoms. We have clues from brain imaging tools that are now incorporated into clinical trials. Mechanism may be beyond a microbiologist like me.

(Microbiology is blissfully simple compared to the human brain, or any brain for that matter.)

We will provide information about medical centers with strong departments of neuroscience and psychiatry who are using new approaches to treatment. Learning how to treat intractable conditions is always fraught, especially if it involves drugs with a prior history.

[See: www.link.springer.com/article/10.1007/s13311-017-0542-y for effects of psilocybin on depression.]


Rich Kessin is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center. Email: Richard.Kessin@gmail.com.

The views expressed here are not necessarily those of The Lakeville Journal and The Journal does not support or oppose candidates for public office.

Latest News

Roomful of Blues set for April 17 show at Infinity Hall in Norfolk
Photo provided

NORFOLK –Roomful of Blues, the Rhode Island-based band hailed by DownBeat magazine as being “in a class by themselves,” will bring its mix of blues, jump, swing, boogie-woogie and soul to Infinity Hall in Norfolk on Friday, April 17, at 8 p.m.

The long-running group, formed in 1967, is touring behind its Alligator Records album Steppin’ Out!, released in late 2025.

Keep ReadingShow less

Robert E. Stapf Sr.

Robert E. Stapf Sr.

MILLERTON — Robert E. Stapf Sr. (Bobbo), a devoted husband, loving father, grandfather, great grandfather, brother and friend to many, passed away peacefully on April 9, 2026, at the age of 77, happily at home surrounded by lots and lots of love and with the best care ever.

Bob was born Jan. 16, 1949, to the late Peter and Dorothy (Fountain) Stapf. He began working at an early age, met his forever love, Sandy, in 7th grade and later graduated from Pine Plains Central School.

Keep ReadingShow less

Michael Joseph Carabine

Michael Joseph Carabine

SHARON — Michael Joseph Carabine, 81, of Sharon, Connecticut, passed away on the morning of Friday, April 3, 2026, at Bryn Mawr Hospital in Bryn Mawr, Pennsylvania. He was the beloved husband of the late Angela Derrico Carabine and loving father to Caitlin Carabine McLean.

Michael was born on April 23, 1944, in Bronx, New York. He was the son of the late Thomas and Kathleen Carabine of New York.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Chion Wolf brings ‘Audacious’ radio show to Winsted with show-and-tell event
Nils Johnson, co-founder and president of The Little Red Barn Brewers in Winsted, hosted Chion Wolf and her Connecticut Public show “Audacious LIVE: Show and Tell,” which was broadcast on April 8, drawing a sold-out crowd.
Jennifer Almquist

The parking lot of The Little Red Barn Brewers in Winsted was full on Wednesday, April 8, as more than 100 people from 43 Connecticut towns — including New Haven and Vernon — arrived carrying personal treasures for a live taping of “Audacious LIVE Show & Tell.”

Chion Wolf, host and producer of Connecticut Public’s “Audacious,” and her crew, led by production manager Maegn Boone, brought the program to the packed brewery for an evening of story-driven conversation and shared keepsakes.

Keep ReadingShow less
Marge Parkhurst, the preservation detective

Marge Parkhurst with a collection of historic nails recovered from wall cavities during restoration work.

Photo courtesy of Marge Parkhurst/Cottage & Country Painting Company
Walls still surprise me. If you look hard enough, you can find buried treasure.
Marge Parkhurst

After nearly 50 years of painting some of Litchfield County’s oldest homes and landmark properties, Marge Parkhurst has developed an eye for the past—reading the clues left behind in stenciled vines, forgotten bottles and newspapers tucked into walls, each revealing a small but vivid piece of Connecticut history.

Parkhurst was stripping wallpaper in a farmhouse in Colebrook — the kind of historic home she has spent decades restoring — when she noticed something odd. Three layers of paper had already come off — each one a different era’s idea of decoration — and beneath them, just barely visible under dull, off-white plaster, a pattern emerged.

Keep ReadingShow less
Wings of Spring performance at the Mahaiwe Theater
Adam Golka
Provided

On Sunday, April 19, at 4 p.m., Close Encounters With Music (CEWM) presents On the Wings of Song at the Mahaiwe Performing Arts Center in Great Barrington.

The program focuses on Robert Schumann’s spellbinding song cycle Dichterliebe (“A Poet’s Love”), a setting of sixteen poems by Heinrich Heine that explores love, longing, and the redemptive power of beauty. Featured artists include John Moore, baritone; Adam Golka, pianist; Miranda Cuckson, viola; and Yehuda Hanani, cello.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.